Pharmacopsychiatry 2013; 46(S 01): S30-S35
DOI: 10.1055/s-0033-1337921
Original Paper
© Georg Thieme Verlag KG Stuttgart · New York

Pathology of Sleep, Hormones and Depression

A. Steiger
1   Department of Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany
,
M. Dresler
1   Department of Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany
,
M. Kluge
1   Department of Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany
2   Department of Psychiatry, University of Leipzig, Leipzig, Germany
,
P. Schüssler
1   Department of Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
18 April 2013 (online)

Abstract

In patients with depression, characteristic changes of sleep electroencephalogram and nocturnal hormone secretion occur including rapid eye movement (REM) sleep disinhibition, reduced non-REM sleep and impaired sleep continuity. Neuropeptides are common regulators of the sleep electroencephalogram (EEG) and nocturnal hormone secretion and changes in their activity appear to contribute to the aberrances of sleep in affective disorders. A reciprocal interaction of the sleep-promoting growth hormone-releasing hormone (GHRH) and corticotrophin-releasing hormone (CRH), which promotes wakefulness and REM sleep, plays a key role in sleep regulation, at least in male subjects. Also galanin and ghrelin promote sleep in men. Neuropeptide Y is involved in the timing of sleep onset. The effects of peptides of sleep are influenced by the time of administration, age, gender and depression. In healthy subjects and in remitted depressed patients motoric memory learning is consolidated during sleep. This effect is absent in depressed patients who are at least 30 years old, and is probably related to elevated glucocorticoid levels.

 
  • References

  • 1 Steiger A. Neurochemical regulation of sleep. J Psychiatr Res 2007; 41: 537-552
  • 2 Kupfer DJ. Sleep research in depressive illness: clinical implications – a tasting menu. Biol Psychiatry 1995; 38: 391-403
  • 3 Bliwise DL. Sleep in normal aging and dementia. Sleep 1993; 16: 40-81
  • 4 Ehlers CL, Reed TK, Henriksen SJ. Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology 1986; 42: 467-474
  • 5 Kimura M, Muller-Preuss P, Lu A et al. Conditional corticotropin-releasing hormone overexpression in the mouse forebrain enhances rapid eye movement sleep. Mol Psychiatry 2010; 15: 154-165
  • 6 Steiger A, Guldner J, Hemmeter U et al. Effects of growth hormone-releasing hormone and somatostatin on sleep EEG and nocturnal hormone secretion in male controls. Neuroendocrinology 1992; 56: 566-573
  • 7 Holsboer F, von Bardeleben U, Steiger A. Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man. Neuroendocrinology 1988; 48: 32-38
  • 8 Ehlers CL, Kupfer DJ. Hypothalamic peptide modulation of EEG sleep in depression: a further application of the S-process hypothesis. Biol Psychiatry 1987; 22: 513-517
  • 9 Mendelson WB, Slater S, Gold P et al. The effect of growth hormone administration on human sleep: a dose-response study. Biol Psychiatry 1980; 15: 613-618
  • 10 Obal J, Krueger JM. GHRH and sleep. Sleep Med Rev 2004; 8: 367-377
  • 11 Friess E, von Bardeleben U, Wiedemann K et al. Effects of pulsatile cortisol infusion on sleep-EEG and nocturnal growth hormone release in healthy men. J Sleep Res 1994; 3: 73-79
  • 12 Steiger A, Guldner J, Knisatschek H et al. Effects of an ACTH/MSH(4-9) analog (HOE 427) on the sleep EEG and nocturnal hormonal secretion in humans. Peptides 1991; 12: 1007-1010
  • 13 Murck H, Antonijevic I, Frieboes RM et al. Galanin has REM-sleep deprivation-like effects on the sleep EEG in healthy young men. J Psychiatr Res 1999; 33: 225-232
  • 14 Saper CB, Chou TC, Scammell TE. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci 2001; 24: 726-731
  • 15 Marshall L, Derad I, Strasburger CJ et al. A determinant factor in the efficacy of GHRH administration in promoting sleep: high peak concentration versus recurrent increasing slopes. Psychoneuroendocrinology 1999; 24: 363-370
  • 16 Schier T, Guldner J, Colla M et al. Changes in sleep-endocrine activity after growth hormone-releasing hormone depend on time of administration. J Neuroendocrinol 1997; 9: 201-205
  • 17 Iovino M, Monteleone P, Steardo L. Repetitive growth hormone-releasing hormone administration restores the attenuated growth hormone (GH) response to GH-releasing hormone testing in normal aging. J Clin Endocrinol Metab 1989; 69: 910-913
  • 18 Guldner J, Schier T, Friess E et al. Reduced efficacy of growth hormone-releasing hormone in modulating sleep endocrine activity in the elderly. Neurobiol Aging 1997; 18: 491-495
  • 19 Antonijevic IA, Murck H, Frieboes RM et al. Sexually dimorphic effects of GHRH on sleep-endocrine activity in patients with depression and normal controls – part I: the sleep EEG. Sleep Res Online 2000; 3: 5-13
  • 20 Antonijevic IA, Murck H, Frieboes RM et al. Sexually dimorphic effects of GHRH on sleep-endocrine activity in patients with depression and normal controls – part II: hormone secretion. Sleep Res Online 2000; 3: 15-21
  • 21 Mathias S, Held K, Ising M et al. Systemic growth hormone-releasing hormone (GHRH) impairs sleep in healthy young women. Psychoneuroendocrinology 2007; 32: 1021-1027
  • 22 Frieboes RM, Murck H, Schier T et al. Somatostatin impairs sleep in elderly human subjects. Neuropsychopharmacology 1997; 16: 339-345
  • 23 Ziegenbein M, Held K, Kuenzel HE et al. The somatostatin analogue octreotide impairs sleep and decreases EEG sigma power in young male subjects. Neuropsychopharmacology 2004; 29: 146-151
  • 24 Schüssler P, Kluge M, Dresler M et al. Sleep-impairing effect of intravenous corticotropin-releasing hormone on sleep EEG in young healthy women. Exp Clin Endocrinol Diabetes 2009; 117: 664
  • 25 Held K, Künzel H, Ising M et al. Treatment with the CRH1-receptor-antagonist R121919 improves sleep-EEG in patients with depression. J Psychiatr Res 2004; 38: 129-136
  • 26 Ehlers CL, Somes C, Lopez A et al. Electrophysiological actions of neuropeptide Y and its analogs: new measures for anxiolytic therapy?. Neuropsychopharmacology 1997; 17: 34-43
  • 27 Ehlers CL, Somes C, Seifritz E et al. CRF/NPY interactions: a potential role in sleep dysregulation in depression and anxiety. Depress Anxiety 1997; 6: 1-9
  • 28 Held K, Antonijevic I, Murck H et al. Neuropeptide Y (NPY) shortens sleep latency but does not suppress ACTH and cortisol in depressed patients and normal controls. Psychoneuroendocrinology 2006; 31: 100-107
  • 29 Hillman JB, Tong J, Tschop M. Ghrelin biology and its role in weight-related disorders. Discov Med 2011; 11: 521-528
  • 30 Weikel JC, Wichniak A, Ising M et al. Ghrelin promotes slow-wave sleep in humans. Am J Physiol – Endocrinol Metab 2003; 284: E407-E415
  • 31 Kluge M, Schüssler P, Zuber V et al. Ghrelin administered in the early morning increases secretion of cortisol and growth hormone without affecting sleep. Psychoneuroendocrinology 2007; 32: 287-292
  • 32 Kluge M, Gazea M, Schüssler P et al. Ghrelin increases slow wave sleep and stage 2 sleep and decreases stage 1 sleep and REM sleep in elderly men but does not affect sleep in elderly women. Psychoneuroendocrinology 2010; 35: 297-304
  • 33 Kluge M, Schüssler P, Zuber V et al. Ghrelin enhances the nocturnal secretion of cortisol and growth hormone in young females without influencing sleep. Psychoneuroendocrinology 2007; 32: 1079-1085
  • 34 Kluge M, Schüssler P, Dresler M et al. Effects of ghrelin on psychopathology, sleep and secretion of cortisol and growth hormone in patients with major depression. J Psychiatr Res 2011; 45: 421-426
  • 35 Kluge M, Schüssler P, Bleninger P et al. Ghrelin alone or co-administered with GHRH or CRH increases non-REM sleep and decreases REM sleep in young males. Psychoneuroendocrinology 2008; 33: 497-506
  • 36 Murck H, Held K, Ziegenbein M et al. Intravenous administration of the neuropeptide galanin has fast antidepressant efficacy and affects the sleep EEG. Psychoneuroendocrinology 2004; 29: 1205-1211
  • 37 Dresler M, Kluge M, Genzel L et al. Impaired off-line memory consolidation in depression. Eur Neuropsychopharmacol 2010; 20: 553-561
  • 38 Genzel L, Ali E, Dresler M et al. Sleep-dependent memory consolidation of a new task is inhibited in psychiatric patients. J Psychiatr Res 2011; 45: 555-560
  • 39 Steiger A, von Bardeleben U, Herth T et al. Sleep EEG and nocturnal secretion of cortisol and growth hormone in male patients with endogenous depression before treatment and after recovery. J Affect Disord 1989; 16: 189-195
  • 40 Dresler M, Kluge M, Pawlowski M et al. A double dissociation of memory impairments in major depression. J Psychiatr Res 2011; 45: 1593-1599
  • 41 Plihal W, Born J. Effects of early and late nocturnal sleep on declarative and procedural memory. J Cogn Neurosci 1997; 9: 534-547
  • 42 Rasch B, Pommer J, Diekelmann S et al. Pharmacological REM sleep suppression paradoxically improves rather than impairs skill memory. Nat Neurosci 2009; 12: 396-397
  • 43 Genzel L, Dresler M, Wehrle R et al. Slow wave sleep and REM sleep awakenings do not affect sleep dependent memory consolidation. Sleep 2009; 32: 302-310
  • 44 Genzel L, Kiefer T, Renner L et al. Sex and modulatory menstrual cycle effects on sleep related memory consolidation. Psychoneuroendocrinology 2012; 37: 987-998
  • 45 Dresler M, Genzel L, Kluge M et al. Off-line memory consolidation impairments in multiple sclerosis patients receiving high-dose corticosteroid treatment mirror consolidation impairments in depression. Psychoneuroendocrinology 2010; 35: 1194-1202
  • 46 Borbély AA. A two-process model of sleep regulation. Hum Neurobiol 1982; 1: 195-204
  • 47 Borbély AA, Wirz-Justice A. Sleep, sleep deprivation and depression: A hypothesis derived from a model of sleep regulation. Hum Neurobiol 1982; 1: 205-210